Email ID
Password
Scrip   
Canadian surge for BMS Parkinson's drug after generic discontinued
02 February 2010
Becky Debens

After just seven months on the Canadian market, Apotex has discontinued making its Parkinson's treatment Apo-Levocarb CR 200/50 (levodopa/carbidopa CR tablets), a generic version of Bristol-Myers Squibb's Sinemet CR.
Apotex said, in a statement, that it had "temporarily discontinued" the product...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36